OCEAN BIOMEDICAL, INC. Deferred Offering Costs
OCEAN BIOMEDICAL, INC. (OCEA) had Deferred Offering Costs of $2.60 million as of 2023-03-31, per its 10-Q/A filed 2024-04-15.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2024-11-25
- 2023-03-31: Deferred Offering Costs $2.60M.
- 2022-12-31: Deferred Offering Costs $1.81M.
- 2021-09-17: Deferred Offering Costs $415.99K; Deferred Offering Costs as first filed $413.95K.
| Period end | Deferred Offering Costs | Deferred Offering Costs as first filed |
|---|---|---|
| 2023-03-31 | $2.60M 10-Q/A · filed 2024-04-15 | |
| 2022-12-31 | $1.81M 10-K · filed 2024-11-25 | |
| 2021-09-17 | $415.99K 10-K · filed 2023-03-31 | $413.95K 10-K · filed 2022-01-31 |